Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Antimicrobial Congress 2021

About Webinar

With great pleasure, we cordially invite all the participants across the world to attend the “3rd International Conference on Antimicrobial and Antibacterial Agents” going to be held on December 14, 2021, Webinar.

This webinar provides a firm platform for scientists, researchers, professors, engineers, and directors of various companies, industrial professionals, and students in the field of microbiology, virology, infectious diseases, and other related fields to share their knowledge. We also take massive pleasure in welcoming various professionals from distinct countries all over the world.

Antimicrobial Congress 2021 is an international platform for building research works and therapeutic findings and disorders related to microbial diseases, viruses, and infections caused by bacteria, and fungi. These types of diseases may be caused due to water-borne, food-borne, and airborne in human beings as well as in plants and animals. When it comes to microbiology and virology the microbes are characterized as the heart for most of the solution of the pressing problems in the world. It also represents the increasing importance of human mortality around the globe; thereby vaccination and vaccine development plays a significant role in terms of global health. Both antimicrobials and antibacterial perform on different types of microorganisms. Antimicrobials destroy or inhibit the growth of all microorganisms, like bacteria, fungi, and viruses.

Target Audience:

  • Directors, Board Members, Presidents, Vice Presidents
  • Deans and Head of the Departments
  • Business Entrepreneurs and Industrialists
  • Microbiologist
  • Virologists 
  • Parasitologist
  • Bacteriologist
  • Pharmacists
  • Epidemiologists
  • Dermatologists
  • Neurologist
  • Ophthalmologist
  • Cardiologist
  • Infectious Diseases Researchers, Scientists, Faculties, Students
  • Infectious Diseases Associations and Societies
  • Medical Colleges, Hospitals & Labs
  • Pharmaceutical Companies and Industries
  • Medical Devices Manufacturing Companies
  • Drug Manufacturing Companies and Industries
  • Laboratory Technicians and Diagnostic Companies

Tracks/Highlights

TRACK 1 : COVID 19 in Antimicrobial and Antibacterial Agents

COVID-19  caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally Bacterial co-infections are correlated with unfavorable outcomes in respiratory viral infections. Despite, microbiological and antibiotic data related to COVID-19 are skimpy, competent use of antibiotics in line with antibiotic stewardship (ABS) principles is guaranteed during the pandemic. Bacterial and fungal co-infections are subtle in COVID-19 patients and are mainly ubiquitous in critically ill patients. In addition, studies are needed to estimate the impact of antimicrobial therapy on therapeutic outcomes in COVID-19 patients to prevent antimicrobial overuse. A novel beta-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was consequently identified as the causative pathogen. Ordinarily, respiratory viral infections are a risk factor for bacterial co-infections, which then increase disease austerity and mortality. It has been established that sepsis and ventilator-associated pneumonia are frequently observed complications in COVID-19 patients.

TRACK 2 : Antimicrobials

The term antimicrobials encompass all agents that act against all types of microorganisms – bacteria (antibacterial), viruses (antiviral), fungi (antifungal), and protozoa (antiprotozoal). By measures to prevent the growth of unwanted microbes, antimicrobial chemicals can help keep people from getting sick. Antimicrobial additives are strikingly diverse and control microbes via many different means. In the manufacture of products, they create surfaces and materials inhospitable to microbes like bacteria and mould. Antimicrobials are the most profitable forms of chemotherapy and have been used to save the human population from the threat of infectious diseases.

TRACK 3 :Vaccine and Vaccination

A vaccine activates our immune system while not making us sick. Various dangerous infectious diseases are often prevented in this simple and effective way. Vaccination could be a simple, safe, and effective way of protecting individuals against harmful diseases, before they are available into contact with them. It uses your body’s natural defenses to make resistance to specific infections and makes your immune system stronger. Vaccines train your immune system to form antibodies, just as it does when it’s exposed to a disease. However, as a result of vaccines contain only killed or weakened varieties of germs like viruses or bacteria, they do not cause the disease or put you at risk of its complications.

TRACK 4 :Microbial Physiology and Metabolism

Microbial physiology  and metabolism add information on sources of energy and its utilization by microorganisms. Microorganisms play vital role in environment as producers, consumers and decomposers. These are the only group of organisms that takes part in all three important stages of ecosystem. Understanding microbial physiology has larger application in industry, developing medicine and even in agriculture. Throughout earth's history, microbial metabolism has been a  thrust behind the development and maintenance of the planet's biosphere. Eukaryotic organisms such as plants and animals generally depend on organic molecules for energy, growth, and reproduction.

TRACK 5 : Pharmaceutical microbiology

Pharmaceutical Microbiology is an applied branch of Microbiology. It involves the study of microorganisms related to the manufacture of pharmaceuticals like minimizing the number of microorganisms in a process environment, excluding microorganisms and microbial byproducts like exotoxin and endotoxin from water and other starting materials, and ensuring the finished pharmaceutical product is sterile. Other aspects of pharmaceutical microbiology include the research and development of anti-infective agents, the use of microorganisms to detect mutagenic and carcinogenic activity in prospective drugs, and the use of microorganisms within the manufacture of pharmaceutical products like insulin and human growth hormone.

TRACK 6 : Microorganisms in Recent Drug Discovery

Microorganisms  stay unrivalled in their ability to produce bioactive small molecules for drug development. Though, the core technologies used to discover microbial natural products have not evolved considerably over the past several decades, resulting in a shortage of new drug leads. Advances in DNA-sequencing and bioinformatics technologies currently build it possible to rapidly determine the clusters of genes that encode bioactive compounds and to make computer predictions of chemical structure based on gene sequence information. These structure predictions can be used to determine new chemical entities and supply necessary physicochemical “handles” that lead compound purification and structure confirmation. Industrialization of this process provides a model for rising the efficiency of natural-product discovery. The application of advanced genomics and bioinformatics technologies is  currently  poised to revolutionize natural-product discovery and lead a renaissance of interest in microorganisms as a supply of bioactive compounds for drug development.

TRACK 7 : Antibiotics, Antimicrobial & Chemotherapy

Antibiotics are a group of medicines that are used to treat infections caused by some germs like bacteria and certain parasites). Usually, people those who need to have an antibiotic by injection are in hospital because they have a severe infection. Whereas, Antimicrobial chemotherapy is the clinical application of antimicrobial agents to treat infectious disease. It involves the administration of drugs with selective toxicity against pathogens concerned in infections, not host cells. Chemotherapeutic agents also known as synthetic antibiotics are the antimicrobial agents of synthetic origin useful in the treatment of microbial or viral disease. Few examples are sulfonilamides, isoniazid, ethambutol, AZT, nalidixic acid and chloramphenicol. Chemotherapeutic agent needs that the agent be used for antimicrobial purpose and excludes synthetic agents used for medical care against diseases that are not of microbial origin.

TRACK 8 : Immunity , Infection Diseases and Agents

The immune system orchestrates a potent defense that consists of the production of specific antibody molecules and lymphocytes capable of reacting with and inactivating foreign agents, either directly or indirectly through the involvement of molecular and cellular inflammatory processes. The human immune system is necessary for our survival in a world full of potentially dangerous microbes, and high impairment of even one arm of this method can predispose to severe, even life-threatening, infections. Infection happens when a pathogen invades body cells and reproduces. Infection will generally lead to an immune response. If the response is fast and effective, the infection will be eliminated or contained so quickly that the disease will not occur. Sometimes infection leads to disease that is marked by symptoms or evidence of illness. Disease may occur when immunity is low or impaired, when virulence of the pathogen (its ability to damage host cells) is high, and when the number of pathogens in the body is great.

TRACK 9 : Antimicrobial Pathogens : Alternative Approaches

Infections of antibiotic-resistant pathogens cause an ever-increasing threat to mankind. The investigation of novel approaches to deal with the antimicrobial resistance crisis should be part of global response to present drawback if an untimely reversion to the pre-penicillin era of medicine is to be avoided. One such promising avenue of analysis involves so-called antibiotic resistance breakers (ARBs), capable of re-sensitising resistant bacteria to antibiotics. Multidrug-resistant bacteria are getting more common and due to their multiplicity of mechanisms, they are frequently resistant to  several if not all of the current antibiotics. This intimidating spectre has been the target of several research efforts into conventional antibiotics and alternative approaches. Bacteria have developed the capability to  supply structured communities (or cluster of cells) via adherence to surface to form biofilms that facilitate or prolong their survival beneath extreme environmental condition.

TRACK 10 :Pharmalogical Consideration of Infectious Disease and Agents

Pandemic, epidemic and endemic infectious diseases are united by a standard problem: how do we quickly and cost-effectively determine potential pharmacological arbitration to treat infections? The growing accessibility of parasite genome data provides the basis for developing methods to prioritize, a priori potential drug targets and analyze the pharmacological landscape of an infectious disease. Infectious diseases create totally different threats to different constituencies and thus are often treated as separate problems by governments, businesses, philanthropies and research funders: neglected diseases are treated as  world health problems; emerging and pandemic diseases  as public health issues; and bio-defence as a national security issue.

TRACK 11:Antimicrobiology in Epidemiology

Antimicrobial resistance has become a serious healthcare problem, with high resistance rates of most common bacteria to clinically important antimicrobial agents. Resistance has emerged to even the newer, almost potent antimicrobial agents. Methicillin-resistant S. aureus, ESBL-producing Enterobacteriaceae and carbapenem-resistant Acinetobacter baumannii represent more than 50% of microbial isolates. Furthermore, bacterial resistance to fluoroquinolones, macrolides and third-generation cephalosporins is of serious concern. The molecular epidemiology and resistance mechanisms of the antimicrobial strains exhibited regional specificity, as well as the influence of dissemination of international clonal complexes.

 

To Collaborate Scientific Professionals around the World

Conference Date December 14-14, 2021

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • Abortion
  • Achromobacter Anitratum
  • Actinobacillus Lignieresi
  • Actinomyces Bovis
  • Acute Flaccid Myelitis (AFM) 
  • Alcaligenes Faecalis
  • Anaplasmosis 
  • Anthrax
  • Anthrax 
  • Antimicrobials
  • Arthritis
  • Babesiosis  Data
  • Bacillus Anthracis
  • Bacteria
  • Botulism
  • Botulism 
  • Brucella Abortus
  • Brucellosis 
  • Calf Necrotic Diphtheria
  • Calf Scours
  • Campylobacteriosis  Data
  • Capsule
  • Carbapenem-resistant Infection (CRE/CRPA) 
  • Chancroid 
  • Chikungunya Virus Infection (Chikungunya) 
  • Chlamydia 
  • Ciguatera (Harmful Algae Blooms (HABs)) 
  • Clostridium Botulinum
  • Clostridium Chauvoei
  • Clostridium Difficile Infection 
  • Clostridium Hemolyticum
  • Clostridium Novyi
  • Clostridium Perfringens
  • Clostridium Perfringens (Epsilon Toxin) 
  • Clostridium Perfringens Type C
  • Clostridium Septicum
  • Coccidioidomycosis Fungal Infection (Valley Fever) 
  • Contagious Bovine Pleuropneumonia
  • Corynebacterium Pyogenes
  • Corynebacterium Renale
  • COVID-19 (Coronavirus Disease 2019) 
  • Creutzfeldt-Jacob Disease, Transmissible Spongiform Encephalopathy (CJD) 
  • Cryptosporidiosis (Crypto)  Data
  • Cystitis
  • Diplococcus Pneumoniae
  • Enteritis
  • Enterobacter Aerogenes
  • Erysipelothrix Insidiosa
  • Escherichia Coli
  • Hemophilus Bovis
  • Hemorrhagic Enterotoxemia
  • Infectious Keratitis
  • Infectious Necrosis Hepatitis
  • Johne’s Disease
  • Klebsiella Pneumoniae
  • Leptospira Hyos
  • Leptospira Icterohaemorrhagica
  • Leptospira Pomona
  • Leptospira Sejroc Phosa
  • Listeria Monocytogenes
  • Listeriosis
  • Microscopic
  • Moraxella Bovis
  • Mycobacterium Paratuberculosis
  • Mycoplasma Mycoides
  • Necrosis Of Rumen
  • Necrotic Abscesses
  • Neonatal Mortality
  • Nephritis
  • Nocardia Asteroides
  • Nocardiosis
  • Pasteurella Haemolytica
  • Pasteurella Multocida
  • Pneumonia
  • Prokaryotic Organisms
  • Proteus Mirabilis
  • Pseudomonas Aeruginosa
  • Pseudomonas Infection
  • Pyelonephritis
  • Pyobacillosis
  • Redwater
  • Salmonella Anatum
  • Salmonella Arizona
  • Salmonella Dublin
  • Salmonella Enteritis
  • Salmonella Newport
  • Salmonella Typhimurium
  • Septicemia
  • Shipping Fever
  • Sphaerophorus Necrophorus
  • Spores
  • Staphylococcus Aureus
  • Streptococcus Agalactiae
  • Streptococcus Pyogenes
  • Streptococcus Uberus
  • Tuberculosis
  • Vibrio Fetus
  • Yersinia Pseudotuberculosis
  •  pneumonia
  •  viral Infections